
|Videos|January 31, 2022
Increased financial coverage for Rezum therapy reaps benefits for patients with BPH
Author(s)Urology Times staff
“I think now the government has realized…the work that’s involved in this procedure…[and] we’re now being reimbursed at an appropriate level,” says David M. Albala, MD.
Advertisement
In this video, David M. Albala, MD, discusses how the recent change made by the Centers for Medicare & Medicaid Services regarding Rezum water vapor therapy will open the doors for more patients to receive this minimally invasive treatment. Albala is a urologist at Associate Medical Professionals and chief of urology at Crouse Hospital in Syracuse, New York.
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA grants 510(k) clearance to Break Wave lithotripsy device for kidney stones
2
Practical guide to female pelvic organ–sparing radical cystectomy
3
CaverSTIM device shows initial promise for post-prostatectomy erectile dysfunction
4
Targeting BCG resistance in high-risk NMIBC
5






